User Settings
Open AccessArticle10.3980/j.issn.2222-3959.2014.04.04

Bevacizumab treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.

Fei Feng,Yan Cheng,Qinghuai Liu-2014-01-01-PubMed
14

TL;DRAbstract

An intravitreal injection of Bevacizumab is able to reduce angioproliferative retinopathy in a mouse model for oxygen-induced retinopathy.

Chat with Paper

AI Agents for this Paper

An intravitreal injection of Bevacizumab is able to reduce angioproliferative retinopathy in a mouse model for oxygen-induced retinopathy.

Keywords

Retinopathy of prematurityRetinalMedicineInner limiting membraneBevacizumabVascular endothelial growth factorRetinaOphthalmology

Chat

Click to start Chat